Our study suggested that the interaction with coagulation system, KRAS signaling, and tumor neutrophil infiltration were the potential mechanisms of Sema3D serving as a tumor suppressor in ccRCC. This evidence concerns the gene KRAS and nonpapillary renal cell carcinoma.